InvestLog
ATON AlphaTON Capital Corp. logo

ATON AlphaTON Capital Corp.

Financial Services
$0.36-5.82%ClosedMarket Cap: $826,570

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.10

P/S

0.00

EV/EBITDA

-0.51

DCF Value

$1.08

FCF Yield

-42.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-925.1%

ROA

-64.4%

ROIC

-116.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q2 null$0.00$-10.4M$—
Q1 null$0.00$-5.6M$—
Q4 null$0.00$-1.9M$—
FY null$0.00$-6.8M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$4.88

Target (Median)

$4.88

Target Range

$4.50 - $5.25

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Kaiser Brittanydirector, officer: Chief Executive Officer
SellFri Apr 17
Terpin Michaeldirector:
SellThu Apr 09
Villani Fiorenzodirector, officer: Chief Investment Officer
SellTue Apr 07
Levitt Wesley Allenofficer
SellWed Mar 18

Company Info

Sector

Financial Services

Industry

Asset Management

Country

US

Exchange

—

Beta

0.49

AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.

Peers

AMTD logoAMTDAURE logoAURECIIT logoCIITFLD logoFLDGSIW logoGSIWKOYN logoKOYNLWAC logoLWACMEGL logoMEGLNCPL logoNCPLOXBR logoOXBR